BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23219677)

  • 21. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.
    Bernardi A; Braganhol E; Jäger E; Figueiró F; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
    Cancer Lett; 2009 Aug; 281(1):53-63. PubMed ID: 19286307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin-loaded lipid-core nanocapsules attenuates the immune challenge LPS-induced in rats: Neuroinflammatory and behavioral response in sickness behavior.
    de Gomes MG; Teixeira FEG; de Carvalho FB; Pacheco CO; da Silva Neto MR; Giacomeli R; Ramalho JB; Dos Santos RB; Domingues WB; Campos VF; Haas SE
    J Neuroimmunol; 2020 Aug; 345():577270. PubMed ID: 32480241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
    Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
    Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of melatonin-loaded lipid-core nanocapsules on paraquat-induced cytotoxicity and genotoxicity in a pulmonary cell line.
    Charão MF; Baierle M; Gauer B; Goethel G; Fracasso R; Paese K; Brucker N; Moro AM; Bubols GB; Dias BB; Matte US; Guterres SS; Pohlmann AR; Garcia SC
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Jun; 784-785():1-9. PubMed ID: 26046970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dithranol-loaded lipid-core nanocapsules improve the photostability and reduce the in vitro irritation potential of this drug.
    Savian AL; Rodrigues D; Weber J; Ribeiro RF; Motta MH; Schaffazick SR; Adams AI; de Andrade DF; Beck RC; da Silva CB
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():69-76. PubMed ID: 25491961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting.
    Hirsjärvi S; Sancey L; Dufort S; Belloche C; Vanpouille-Box C; Garcion E; Coll JL; Hindré F; Benoît JP
    Int J Pharm; 2013 Sep; 453(2):594-600. PubMed ID: 23747436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration.
    Bulcão RP; de Freitas FA; Dallegrave E; Venturini CG; Baierle M; Durgante J; Sauer E; Cassini C; Cerski CT; Zielinsky P; Salvador M; Pohlmann AR; Guterres SS; Garcia SC
    Eur J Pharm Biopharm; 2014 Feb; 86(2):167-77. PubMed ID: 23643792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer.
    Montigaud Y; Ucakar B; Krishnamachary B; Bhujwalla ZM; Feron O; Préat V; Danhier F; Gallez B; Danhier P
    Int J Pharm; 2018 Nov; 551(1-2):322-328. PubMed ID: 30236645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
    Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
    Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model.
    Komninou ER; Remião MH; Lucas CG; Domingues WB; Basso AC; Jornada DS; Deschamps JC; Beck RC; Pohlmann AR; Bordignon V; Seixas FK; Campos VF; Guterres SS; Collares T
    PLoS One; 2016; 11(6):e0157561. PubMed ID: 27310006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells.
    Schultze E; Coradini K; Dos Santos Chaves P; da Silva LP; Buss J; Guterres SS; Collares T; Beck RCR; Pohlmann AR; Seixas FK
    Pharmacol Rep; 2017 Dec; 69(6):1408-1412. PubMed ID: 29154195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
    Bruinsmann FA; de Cristo Soares Alves A; de Fraga Dias A; Lopes Silva LF; Visioli F; Raffin Pohlmann A; Figueiró F; Sonvico F; Stanisçuaski Guterres S
    Int J Pharm; 2022 Mar; 616():121563. PubMed ID: 35151819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
    Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
    J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
    Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
    AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
    Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
    Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoencapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrations.
    Friedrich RB; Dimer FA; Guterres SS; Beck RC; Pohlmann AR
    J Biomed Nanotechnol; 2014 Aug; 10(8):1599-609. PubMed ID: 25016659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: Cytotoxicity in human breast cancer cell line and in vitro uptake mechanism.
    Antonow MB; Asbahr ACC; Raddatz P; Beckenkamp A; Buffon A; Guterres SS; Pohlmann AR
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():374-382. PubMed ID: 28482541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.
    Bernardi A; Frozza RL; Jäger E; Figueiró F; Bavaresco L; Salbego C; Pohlmann AR; Guterres SS; Battastini AM
    Eur J Pharmacol; 2008 May; 586(1-3):24-34. PubMed ID: 18371953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis.
    El-Sheridy NA; Ramadan AA; Eid AA; El-Khordagui LK
    Colloids Surf B Biointerfaces; 2019 Sep; 181():623-631. PubMed ID: 31202972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.
    Lacoeuille F; Garcion E; Benoit JP; Lamprecht A
    J Nanosci Nanotechnol; 2007 Dec; 7(12):4612-7. PubMed ID: 18283853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.